[Skip to Content]

Upstate Active Clinical Trials

Study Title:

EA5181: Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC

Upstate Institutional Review Board (IRB) Number:

1610017

Study/Protocol ID:

EA5181

Study Phase:

III

Patient Age Group:

Adults

Principal Investigator:

Stephen L Graziano, MD

What is involved if I participate?

  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    No

Where will the study take place?

Upstate- all procedures
Oswego- all procedures
Oneida- all procedures
The Hill- radiation therapy

ClinicalTrials.Gov ID:

NCT04092283

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Eunice B Awuah, PhD
Phone: 315-464-5934
Email: awuahe@upstate.edu

Return to Previous Page || Search Again

Top